Bonesupport Hold
Stock
Stock
ISIN: SE0009858152
Ticker: BONEX
SE0009858152
BONEX
Price
Price
CHART BY
Frequently asked questions
What is Bonesupport Hold's market capitalization?
The market capitalization of Bonesupport Hold is $1.44B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Bonesupport Hold's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Bonesupport Hold is 66.75. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Bonesupport Hold?
Bonesupport Hold's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.329. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Bonesupport Hold's stock?
Currently, 6 analysts cover Bonesupport Hold's stock, with a consensus target price of $35.01. Analyst ratings provide insights into the stock's expected performance.
What is Bonesupport Hold's revenue over the trailing twelve months?
Over the trailing twelve months, Bonesupport Hold reported a revenue of $130.35M.
What is the EBITDA for Bonesupport Hold?
Bonesupport Hold's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $32.33M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Bonesupport Hold?
Bonesupport Hold has a free cash flow of $26.77M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Bonesupport Hold's shares?
The free float of Bonesupport Hold is 59.28M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.44B
- EPS (TTM)
- $0.329
- Free Float
- 59.28M
- P/E ratio (TTM)
- 66.75
- Revenue (TTM)
- $130.35M
- EBITDA (TTM)
- $32.33M
- Free Cashflow (TTM)
- $26.77M
Pricing
- 1D span
- $21.47$21.95
- 52W span
- $17.97$32.92
Analyst Ratings
The price target is $35.01 and the stock is covered by 6 analysts.
Buy
6
Hold
0
Sell
0
Information
BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0009858152
- Primary Ticker
- BONEX
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet